Ozanimod | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ozanimod
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Ozanimod

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

20 API Suppliers, 6 USDMF, 1 EU WC, 8 NDC API, 10 Listed Suppliers, $ API Reference Price

20 API Suppliers
6 USDMF
1 EU WC
8 NDC API
10 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

66 Drugs in Development

66 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 5 FDA Orange Book, 5 Europe, 5 Australia, 3 Listed Dossiers

18 FDF Dossiers
5 FDA Orange Book
5 Europe
5 Australia
3 Listed Dossiers

DIGITAL CONTENT

1 Stock Recap #PipelineProspector, 65 News #PharmaBuzz

1 Stock Recap #PipelineProspector
65 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 5 Annual Reports

1 US Medicaid Prescriptions
5 Annual Reports

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

18 US Patents, 6 US Exclusivities, 6 Health Canada Patents

18 US Patents
6 US Exclusivities
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 257,511 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6McCarthy Tétrault

filter Patent Reset all filters

6 All

01 32723904

02 32780772

filter Product Reset all filters

6 All

01 6OZANIMOD HYDROCHLORIDE

filter Dosage Reset all filters

6 All

01 4CAPSULE

02 2KIT

filter Exp Date Reset all filters

6 All

01 32029-05-14

02 32030-11-15

Product Main Page

01

McCarthy Tétrault

OZANIMOD HYDROCHLORIDE

Formnext Forum

Not Confirmed

McCarthy Tétrault

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

OZANIMOD HYDROCHLORIDE

Brand Name : ZEPOSIA

Patent Number : 2723904

Filing Date : 2009-05-14

Strength per Unit : 0.92 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

McCarthy Tétrault

OZANIMOD HYDROCHLORIDE

Formnext Forum

Not Confirmed

McCarthy Tétrault

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

OZANIMOD HYDROCHLORIDE

Brand Name : ZEPOSIA

Patent Number : 2723904

Filing Date : 2009-05-14

Strength per Unit : 0.23 mg / 0.46 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

McCarthy Tétrault

OZANIMOD HYDROCHLORIDE

Formnext Forum

Not Confirmed

McCarthy Tétrault

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

OZANIMOD HYDROCHLORIDE

Brand Name : ZEPOSIA

Patent Number : 2723904

Filing Date : 2009-05-14

Strength per Unit : 0.23 mg / 0.46 mg

Dosage Form : KIT

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

McCarthy Tétrault

OZANIMOD HYDROCHLORIDE

Formnext Forum

Not Confirmed

McCarthy Tétrault

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

OZANIMOD HYDROCHLORIDE

Brand Name : ZEPOSIA

Patent Number : 2780772

Filing Date : 2010-11-15

Strength per Unit : 0.92 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

McCarthy Tétrault

OZANIMOD HYDROCHLORIDE

Formnext Forum

Not Confirmed

McCarthy Tétrault

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

OZANIMOD HYDROCHLORIDE

Brand Name : ZEPOSIA

Patent Number : 2780772

Filing Date : 2010-11-15

Strength per Unit : 0.23 mg / 0.46 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

McCarthy Tétrault

OZANIMOD HYDROCHLORIDE

Formnext Forum

Not Confirmed

McCarthy Tétrault

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

OZANIMOD HYDROCHLORIDE

Brand Name : ZEPOSIA

Patent Number : 2780772

Filing Date : 2010-11-15

Strength per Unit : 0.23 mg / 0.46 mg

Dosage Form : KIT

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!